XML 78 R37.htm IDEA: XBRL DOCUMENT v2.3.0.15
ALLIANCES AND COLLABORATIONS (Sanofi) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Dec. 31, 2010
Dec. 31, 2001
Alliances and Collaborations Statement [Line Items]      
Net sales$ 5,345$ 4,798$ 15,790$ 14,373  
Distributions  (1,842)(1,613)  
Equity in net income of affiliates(71)(70)(215)(252)  
Other (income)/expense(26)(10)(195)84  
Sanofi [Member] | Territory Covering Americas and Australia [Member] | AVAPRO, AVALIDE, and PLAVIX [Member]
      
Alliances and Collaborations Statement [Line Items]      
Controlling interest ownership percentage50.10% 50.10%   
Noncontrolling interest ownership percentage49.90% 49.90%   
Net sales1,9361,8745,9595,580  
Discovery royalty expense3683371,123998  
Noncontrolling interest - pre-tax5905231,7641,543  
Distributions(523)(545)(1,824)(1,598)  
Sanofi [Member] | Europe Comarketing Countries and Other [Member] | AVAPRO, AVALIDE, and PLAVIX [Member]
      
Alliances and Collaborations Statement [Line Items]      
Net sales6887213295  
Sanofi [Member] | Territory Covering Europe and Asia [Member] | AVAPRO, AVALIDE, and PLAVIX [Member]
      
Alliances and Collaborations Statement [Line Items]      
Controlling interest ownership percentage50.10% 50.10%   
Equity method investment ownership percentage49.90% 49.90%   
Equity in net income of affiliates(75)(73)(226)(261)  
Profit distributions to the Company9785224239  
Investment in affiliates24 24 22 
Net sales3644171,1251,465  
Gross profit161174501662  
Net income131141413528  
Sanofi [Member] | United States [Member] | AVAPRO AVALIDE [Member] | License Fee [Member]
      
Alliances and Collaborations Statement [Line Items]      
Payment to the Company for an interest in a license     350
Amortization income - upfront, milestone and other licensing payments(7)(7)(23)(23)  
Deferred income37 37 60 
Sanofi [Member] | AVAPRO, AVALIDE, and PLAVIX [Member] | Supply Activities And Development And Opt Out Royalties [Member]
      
Alliances and Collaborations Statement [Line Items]      
Other (income)/expense6321(28)  
AVAPRO AVALIDE [Member]
      
Alliances and Collaborations Statement [Line Items]      
Net sales$ 216$ 303$ 757$ 924